|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/47 | (2006.01) |
| C12N 9/26 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 3436053 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17719388.5 |
| Date of filing the European patent application | 2017-03-30 | |
| (97) | Date of publication of the European application | 2019-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-06 |
| (46) | Date of publication of the claims translation | 2022-07-11 |
| (86) | Number | PCT/US2017/024982 |
| Date | 2017-03-30 |
| (87) | Number | WO 2017/173060 |
| Date | 2017-10-05 |
| (30) | Number | Date | Country code |
| 201662315436 P | 2016-03-30 | US | |
| 201762457588 P | 2017-02-10 | US |
| (72) |
CHAR, Hing , US
TESLER, Sergey , US
SUNDERLAND, Wendy , US
DILONÉ, Enrique , US
DO, Hung , US
GOTSCHALL, Russell , US
|
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos, apimančios rekombinantinę rūgštinę alfa-gliukozidazę |
| FORMULATIONS COMPRISING RECOMBINANT ACID ALPHA-GLUCOSIDASE |
| Payment date | Validity (years) | Amount | |
| 2025-02-27 | 9 | 208.00 EUR |
| 2026-03-30 |